We are live on ! Find out more
CANF icon

Can-Fite BioPharma American Depositary Shares
CANF

4 hedge funds and large institutions have $2.18M invested in Can-Fite BioPharma American Depositary Shares in 2014 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,872% more capital inflows, than outflows

Capital inflows: $1.69M | Capital outflows: $34K

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

100% more funds holding

Funds holding: 2 → 4 (+2)

0.16% more ownership

Funds ownership: 0.04% → 0.21% (+0.16%)

Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$10K
2
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
+$10K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$33K
2
Ameriprise
Ameriprise
Minnesota
-$1K

CANF Hedge Fund Activity: Q4 2014 in Review

4 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q4 2014, worth a combined $2.18M — up 424% from $416K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CANF positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $10K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $33K sold.

  • 4 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q4 2014, up from 2 in Q3 2014.
  • Funds reported $2.18M of Can-Fite BioPharma American Depositary Shares stock for Q4 2014, up 424% quarter-over-quarter.
  • 3 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q4 2014 and 1 closed out, a net change of +2 holders.
  • The largest Can-Fite BioPharma American Depositary Shares buyer in Q4 2014 was Morgan Stanley, an estimated $10K added.
  • The largest Can-Fite BioPharma American Depositary Shares seller in Q4 2014 was Susquehanna International Group, an estimated $33K sold.

Based on aggregated 13F filings for Q4 2014.